Dr. J. Victor Garcia-Martinez's lab focuses on understanding the effects of cannabinoids on HIV infection, particularly in the brain, and developing gene and cell therapies for curing HIV. The research explores how substances like cannabis can modulate immune responses in people living with HIV and aims to improve therapeutic strategies to eliminate the virus from reservoirs within the body.

Dr. Hui Hu's research lab at the University of Alabama at Birmingham focuses on understanding how CD4+ T cells, which are crucial for our immune responses, differentiate into various types, including memory cells. This lab studies the complex genetic and molecular processes that govern these cells' development, especially how they form during initial immune responses and later evolve into specialized types that help fight infections. Their work has significant implications for vaccine development and the treatment of immune-related diseases.

Dr. Michael Niederweis' lab investigates how the bacterium Mycobacterium tuberculosis survives within the human host. They focus on the secretion of toxins and siderophores, which help the bacteria evade the immune system and acquire essential nutrients like iron. By studying these mechanisms, the lab aims to identify potential targets for new tuberculosis treatments and improve our understanding of how this pathogen causes disease.

Dr. Carlos Orihuela's lab at the University of Alabama at Birmingham focuses on understanding how the bacterium Streptococcus pneumoniae invades organs during infections. By exploring the molecular mechanisms behind its attachment to cells and its ability to evade the immune response, the lab aims to improve strategies for vaccine design. Their research is crucial for developing better approaches to prevent severe illnesses caused by this pathogen.

Dr. Allan Zajac's lab at the University of Alabama at Birmingham focuses on understanding how immune cells, particularly T cells, become exhausted during chronic viral infections like HIV, HBV, and HCV. The research aims to discover the roles of specific immune signals, such as IL-2, in shaping the T cell response, which is crucial for improving treatments and immune responses in chronic infections. This work has significant implications for enhancing public health strategies against viral diseases by restoring effective immune function.

Jan Novak's lab at the University of Alabama at Birmingham focuses on understanding the molecular mechanisms involved in IgA nephropathy (IgAN), a leading cause of kidney failure. The research aims to identify the characteristics and biological activities of IgA1-containing immune complexes in patients with this disease. By studying these complexes, the lab seeks to uncover the factors that influence disease progression and develop targeted therapies.

Dr. Masakazu Kamata's lab focuses on developing advanced therapies for cancer treatment through innovative drug delivery systems. By engineering a special polymer called PMPC, they enhance the effectiveness of antibody-drug conjugates (ADCs), ensuring these drugs can target tumors more accurately and penetrate areas like the brain. This research aims to create safer, more efficient cancer treatments that can improve patient outcomes.

Dr. Terje Dokland's lab at the University of Alabama at Birmingham studies the structure and assembly mechanisms of the HIV-1 virus. Specifically, the lab is focused on how the virus's proteins are structured and interact during its lifecycle, which is critical for developing new therapies against HIV. The aim is to understand how the HIV virus assembles and matures, which could lead to innovative antiviral strategies.

Dr. Frances E. Lund's research lab focuses on understanding the memory B and T cells of the human immune system, particularly in the context of organ transplantation. They investigate how these cells evolve and persist over time, especially in tissues vital for transplant success. Their work aims to uncover insights that could lead to improved treatments for transplant patients by balancing protective and damaging immune responses.

Dr. Angela Raquel Wahl's lab focuses on understanding the role of myeloid cells, particularly microglia, in the persistence of HIV in the brain. By studying these cells in a humanized mouse model, her research aims to uncover how HIV might hide in the brain, avoid eradication strategies, and lead to complications in patients even when treated with antiretroviral therapy. Ultimately, this work seeks to contribute to the development of more effective HIV cure strategies that can target the central nervous system.